Senescent cell-derived inhibitors of dna synthesis

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/12 (2006.01) A61K 9/127 (2006.01) A61K 31/70 (2006.01) A61K 38/17 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C12N 15/62 (2006.01) C12N 15/88 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2235810

The use of liposomal formulations, particularly formulations of positively charged and neutral lipids facilitates cellular uptake of SDI molecules. The transcription and/or expression of SDI-1-encoding nucleic acid molecules is facilitated by constructs that contain intervening untranslated regions.

L'utilisation de formulations liposomiques, en particulier, des formulations de lipides neutres et positivement chargés facilite le captage cellulaire de molécules d'inhibiteurs produits dans des cellules sénescentes (SDI). La transcription et/ou l'expression de molécules d'acide nucléique codant SDI-1 est facilitée par des produits de recombinaison contenant des régions intervenantes non traduites.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Senescent cell-derived inhibitors of dna synthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Senescent cell-derived inhibitors of dna synthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Senescent cell-derived inhibitors of dna synthesis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1499296

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.